Scientific Online Resource System

Annual for Hospital Pharmacy

Study of the clinical pharmacist role in preparation and application of radiopharmaceuticals

Stanislava Yordanova, Ilko Getov


Introduction: The use of a specific type of radioactive medicinal products and medical devices is a unique opportunity of Nuclear medicine for visualization the morphology of organs, their functions and dysfunctions as well for staging and treatment of diseases. Very important role in this process has the clinical pharmacist through monitoring and control of a potential drug related risks and assistance for ensuring optimal application of this specific kind pharmaceuticals.

Objective: To explore a various opportunities for optimize the preparation and application processes of radiopharmaceuticals in clinical setting in Bulgaria through the participation of a clinical pharmacist in the multidisciplinary team of healthcare specialists in the Nuclear medicine departments.

Materials and methodology: The systematic review of literature data is based on key words: radiopharmaceutical, clinical pharmacist, nuclear medicine, good practices, national standard of nuclear medicine in the following bibliographic databases: Scopus, Medline, Springer, Embase, and others. The analysis is performed grounded on the current legislation of the Republic of Bulgaria, which regulates activities pertaining to radioactive pharmaceutical products, radiopharmaceutical, radionuclide generators, kits, radionuclide precursors, as well as the educational regulations for all experts participating in such activities.

Results and discussions: All radiopharmaceutical medicinal products (RPMP) hide potential risk of drug interactions (DI) and adverse drug reactions (ADR). The expertise of a clinical pharmacist plays an important role in the therapeutic and diagnostic processes and is applicable to avoiding potential risks, consulting the patient regarding their behavior in the event such risks cannot be avoided or have already taken place. Potential DI with RPMP present changes in the biological distribution of the radiopharmaceuticals in the physiological compartments, changed absorption, accelerated elimination, pharmacological, pharmaceutical and/or toxic interactions. Some RPMP can extend or reduce their accumulation in the targeted organs and influence the diagnostic and therapeutical results.

Conclusion: The participation of a clinical pharmacist in the preparation and application of radioactive medicinal products, radionuclide generators, kits, and radionuclide precursors as a part of the healthcare team can present a real opportunity for the optimization of such processes, as well as the improvement of the diagnostic and therapeutic outcomes of the patients in a clinical setting.


radiopharmaceutical, clinical pharmacist, nuclear medicine, good practices, national standard of nuclear medicine.

Full Text


Report of the Committee on Isotopes of the American Society of Hospital Pharmacists, 1954.

Radiopharmaceuticals: Production and Availability. International Atomic Energy Agency. Отворен сайт, октом¬ври 2016 г.: Documents/ .

Sgouros G, Goldenberg DM. Radiopharmaceutical Therapy in the Era of Precision Medicine. Eur J Cancer. 2014 Sep; 50(13): 2360–2363.

RADIOPHARMACEUTICALS Final text for addition to The International Pharmacopoeia (November 2008). Document QAS/08.262/FINAL November 2008. WHO.

Owunwanne A, Patel M, Sadek S. The Handbook of Radiopharmaceuticals. Chapter: Preparation of radiopharmaceuticals, pp 3-15.

EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use Annex 3 Manufacture of Radiopharmaceuticals. Отворен сайт: files/eudralex/vol-4/2008_09_annex3_en.pdf.

What is nuclear pharmacy? Достъпна на адрес:, отворен на 03.03.2017 г.

Nuclear pharmacist. Достъпна на интернет адрес: http://, отворена на 2.02.2017 г.

Beach TA, Griffith K, Dam HQ, Manzone TA. Ensuring safe and quality medication use in nuclear medicine: A collaborative team achieves compliance with medication management standards. J Nucl Med Technol. 2012; 40:1–10.

Shaw SM, Ice RD. Nuclear pharmacy, Part I: Emergence of the specialty of nuclear pharmacy. J Nucl Med Technol. 2000; 28:8–11.

Patel J, Sandipkumar B. Clinical Pharmacists in Nuclear Medicine: A New Role in Ascendancy. Indian Journal of Pharmacy Practice, 2014; 7(3):14-18

Parasuraman S, Mueen Ahmed KK, Bin Hashim TS et al. Knowledge about the availability of the pharmacist in the Nuclear Medicine Department: A questionnaire-based study among health-care professionals. Journal of Basic and Clinical Pharmacy. 2014; 6(1):19-23.

Гетов И, Насева Е, Лебанова Х, Григоров Е. Основи на фармакоепидемиологията. ЕкоПринт – София. 2013. ISBN 978-954-92284-9-6

Специалност Ядрена химия, магистърска програма Ради¬охимия и радиоекология. Отворен сайт:

Иновационна стратегия за интелигентна специализация в Република България 20142020 година. Отворен сайт: http://

Най-големият циклотрон на Балканите ще е в София. От¬ворен сайт: 21439995.

КХП на Poltechnet 8.0-175 GBq radionuclide generator.



Article Tools
Email this article (Login required)